Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate the clinical tolerability of the NUVANCEā„¢ Facial Rejuvenation System for correcting neck, mid-face and/or jowl ptosis.


Clinical Trial Description

This is a multicenter, prospective, single-arm study. The primary tolerability endpoint will be evaluated up to 30-days post-operatively. Secondary endpoints will be evaluated at 6-months. Extended follow-up will be conducted at 12-months, 24-months, and 36-months. ;


Study Design


Related Conditions & MeSH terms

  • Ptosis of the Neck, Mid-face and/or Jowl

NCT number NCT01100190
Study type Interventional
Source Ethicon, Inc.
Contact
Status Terminated
Phase N/A
Start date March 1, 2010
Completion date March 1, 2014